高级检索

多肽药物关键水解酶体外高通量分析方法的建立

Establishment of a high-throughput analysis method for the identification of key proteases of peptide drugs in vitro

  • 摘要: 为了建立测定多肽药物体内代谢关键水解酶的高通量分析方法,本研究基于高效液相色谱技术,确定通用的体外酶解反应条件为:pH 7.8或9.0,缓冲体系为0.01 mol/L PBS或50 mmol/L Tris缓冲液,实现对多肽药物关键水解酶的统一高通量体外检测。利用该方法对多肽药物普兰林肽的关键水解酶进行分析,研究结果显示,基肽释放相关酶5和二肽基肽酶4对普兰林肽的水解作用最强,与微量热泳动分析结果一致。因此,本研究所建立的方法可用于分析多肽药物的关键水解酶,为优化多肽药物的酶稳定性提供方法参考与指导。

     

    Abstract: In order to establish an effective analytical method to detect the key proteases which affect the metabolism and the plasma half-life of peptides in vivo, a method to analyze the key proteases of peptide drugs based on high performance liquid chromatography in vitro was established. The general enzymatic reaction conditions in vitro were as follows: pH was 7. 8 or 9. 0 and the buffer system was 0. 01 mol/L PBS or 50 mmol/L Tris buffer. The results of pramlintide detected by this method showed that kallikrein-related peptidase 5 and dipeptidyl peptidase 4 had the strongest hydrolysis on pramlintide. The result was consistent with that determined by microscale thermophoresis, which indicated that kallikrein-related peptidase 5 and dipeptidyl peptidase 4 were the key proteases of pramlintide. This analytical method provides the basis for high-throughput stability screening of peptides and can be used to analyze key proteases of peptide drugs. It can also provide guidance for optimizing the protease stability of peptide drugs.

     

/

返回文章
返回